Benzinga | Nov 9, 2020 04:22PM EST

Altimmune Q3 EPS $(0.54) Beats $(0.76) Estimate

Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.76) by 28.95 percent. This is a 27.03 percent increase over losses of $(0.74) per share from the same period last year.